TrialFrontiers in immunology2018

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.

Peter J Darlington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.